Assessing the Risk of Decrease in Kidney Function in Patients Prescribed Direct-Acting Antivirals for Hepatitis C Utilizing the MID-NET(®) Medical Information Database Network in Japan

An association between kidney disease and direct-acting antivirals against hepatitis C (DAAs) has been suggested, however the warning on the package insert (PI) of the drug varies among DAAs. In this study, the risk of decreased kidney function associated with DAAs marketed in Japan was investigated...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Tomoaki, Sawada, Sono, Ishiguro, Chieko, Ando, Takashi, Kobayashi, Kanae, Komiyama, Noriyuki, Iguchi, Toyotaka, Nonaka, Takahiro, Uyama, Yoshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135840/
https://www.ncbi.nlm.nih.gov/pubmed/35437631
http://dx.doi.org/10.1007/s43441-022-00400-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135840/
https://www.ncbi.nlm.nih.gov/pubmed/35437631
http://dx.doi.org/10.1007/s43441-022-00400-5

Ejemplares similares